R-CHOP therapy alone in limited stage diffuse large B-cell lymphoma. (Q51829492)

13 April 2018

title

R-CHOP therapy alone in limited stage diffuse large B-cell lymphoma. (English)

1 reference

13 April 2018

author name string

Naoto Tomita

1

1 reference

13 April 2018

Hirotaka Takasaki

2

1 reference

13 April 2018

Kazuho Miyashita

3

1 reference

13 April 2018

Shin Fujisawa

4

1 reference

13 April 2018

Eriko Ogusa

5

1 reference

13 April 2018

Shiro Matsuura

6

1 reference

13 April 2018

Kumiko Kishimoto

7

1 reference

13 April 2018

Ayumi Numata

8

1 reference

13 April 2018

Atsuko Fujita

9

1 reference

13 April 2018

Rika Ohshima

10

1 reference

13 April 2018

Hideyuki Kuwabara

11

1 reference

13 April 2018

Maki Hagihara

12

1 reference

13 April 2018

Chizuko Hashimoto

13

1 reference

13 April 2018

Sachiya Takemura

14

1 reference

13 April 2018

Hideyuki Koharazawa

15

1 reference

13 April 2018

Etsuko Yamazaki

16

1 reference

13 April 2018

Katsumichi Fujimaki

17

1 reference

13 April 2018

Jun Taguchi

18

1 reference

13 April 2018

Rika Sakai

19

1 reference

13 April 2018

Yoshiaki Ishigatsubo

20

1 reference

13 April 2018

language of work or name

English

0 references

publication date

25 February 2013

1 reference

13 April 2018

British Journal of Haematology

published in

1 reference

13 April 2018

volume

161

1 reference

13 April 2018

page(s)

383-388

1 reference

13 April 2018

issue

3

1 reference

13 April 2018

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

cites work

1 reference

Revised response criteria for malignant lymphoma.

21 January 2018

1 reference

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

21 January 2018

1 reference

Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484.

21 January 2018

1 reference

Localized large cell lymphoma: is there any need for radiation therapy?

21 January 2018

1 reference

Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014.

21 January 2018

1 reference

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

21 January 2018

1 reference

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group

21 January 2018

1 reference

ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma

21 January 2018

1 reference

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

21 January 2018

1 reference

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

21 January 2018

1 reference

Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.12281

1 reference

13 April 2018

PubMed ID

23432318

1 reference

13 April 2018